Senate Finance Committee Issues Joint Testimony From FDA
June 03, 2020
June 03, 2020
WASHINGTON, June 3 -- The Senate Finance Committee issued the following joint testimony by Judith A. McMeekin, associate commissioner for regulatory affairs, Mark Abdoo, associate commissioner for global policy and strategy, and Douglas Throckmorton, deputy director for regulatory programs at the Health and Human Services Department's Food and Drug Administration, at a hearing entitled "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" on June 2 . . .